AlphaStocks
4.3
Weak

ACADIA PHARMACEUTICALS INC (ACAD)

Health Care / Pharmaceuticals

S&P SmallCap 600

$20.69

Below average on several measures. Research carefully.

Weak

Score based on 3 of 5 models — moderate confidence

#775out of 1125 in Health Care

Is ACADIA PHARMACEUTICALS INC a Good Investment in 2026?

ACADIA PHARMACEUTICALS INC (ACAD) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates ACADIA PHARMACEUTICALS INC as Attractive (5/9). The Graham model is the least favorable, rating it Neutral. ACADIA PHARMACEUTICALS INC ranks #775 out of 1125 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E9.0ROE12.9Market Cap4B

Valuation

Trades at 9x earnings — near sector median of 25x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Neutral

Business quality & competitive moat

Graham

Neutral

30% below fair value

Lynch

Limited Data

Growth rate vs price (PEG)

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is ACADIA PHARMACEUTICALS INC (ACAD) a good investment?
Based on AlphaStocks' composite analysis, ACADIA PHARMACEUTICALS INC (ACAD) scores 4.3 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trades at 9x earnings — near sector median of 25x.
What is ACADIA PHARMACEUTICALS INC's Piotroski F-Score?
ACADIA PHARMACEUTICALS INC's Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ACAD overvalued or undervalued?
A precise fair value estimate is not available for ACAD. Trades at 9x earnings — near sector median of 25x.
How does ACAD compare to other Health Care stocks?
ACADIA PHARMACEUTICALS INC ranks #775 out of 1125 stocks in the Health Care sector, placing it in the top 69% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about ACAD?
AlphaStocks evaluates ACAD using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Neutral. These models are combined into a single composite score of 4.3/10.

Similar Stocks

BFAMAZNKLIC

Compare ACAD with

ACAD vs BFAMACAD vs AZNACAD vs KLIC

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer